Literature DB >> 19268606

Memory T cells need CD28 costimulation to remember.

Alina C Boesteanu1, Peter D Katsikis.   

Abstract

The activation and expansion of naïve T cells require costimulatory signals provided by CD28 and TNF family members. In contrast, for many years it was believed that memory T cells do not require CD28 costimulation for expansion during secondary responses. This was based on in vitro experiments that suggested the re-activation of memory T cells is somewhat independent of costimulation. Recent in vivo evidence, however, has challenged this and shown that both CD4+ and CD8+ memory T cells require CD28 costimulation for maximal expansion and pathogen clearance. This requirement has important implications for host immunity, vaccine development and immunotherapeutics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19268606      PMCID: PMC2923542          DOI: 10.1016/j.smim.2009.02.005

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  130 in total

1.  CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.

Authors:  J R Abrams; M G Lebwohl; C A Guzzo; B V Jegasothy; M T Goldfarb; B S Goffe; A Menter; N J Lowe; G Krueger; M J Brown; R S Weiner; M J Birkhofer; G L Warner; K K Berry; P S Linsley; J G Krueger; H D Ochs; S L Kelley; S Kang
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Medullary thymic epithelium expresses a ligand for CTLA4 in situ and in vitro.

Authors:  A J Nelson; S Hosier; W Brady; P S Linsley; A G Farr
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

Review 3.  Tolerance, danger, and the extended family.

Authors:  P Matzinger
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

4.  Differential T cell costimulatory requirements in CD28-deficient mice.

Authors:  A Shahinian; K Pfeffer; K P Lee; T M Kündig; K Kishihara; A Wakeham; K Kawai; P S Ohashi; C B Thompson; T W Mak
Journal:  Science       Date:  1993-07-30       Impact factor: 47.728

Review 5.  Tumor necrosis factor receptor superfamily members and their ligands.

Authors:  R J Armitage
Journal:  Curr Opin Immunol       Date:  1994-06       Impact factor: 7.486

6.  B7 expression on thymic medullary epithelium correlates with epithelium-mediated deletion of V beta 5+ thymocytes.

Authors:  S Degermann; C D Surh; L H Glimcher; J Sprent; D Lo
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

7.  Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells.

Authors:  M Croft; L M Bradley; S L Swain
Journal:  J Immunol       Date:  1994-03-15       Impact factor: 5.422

8.  Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules.

Authors:  J W Hodge; S Abrams; J Schlom; J A Kantor
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

9.  Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.

Authors:  L Chen; P McGowan; S Ashe; J Johnston; Y Li; I Hellström; K E Hellström
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

10.  T cell affinity maturation by selective expansion during infection.

Authors:  D H Busch; E G Pamer
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

View more
  56 in total

1.  Differential requirements for CD80/86-CD28 costimulation in primary and memory CD4 T cell responses to vaccinia virus.

Authors:  Shinichiro Fuse; Ching-Yi Tsai; Leah M Rommereim; Weijun Zhang; Edward J Usherwood
Journal:  Cell Immunol       Date:  2010-10-30       Impact factor: 4.868

Review 2.  Bispecific antibodies for cancer therapy: the light at the end of the tunnel?

Authors:  Patrick Chames; Daniel Baty
Journal:  MAbs       Date:  2009 Nov-Dec       Impact factor: 5.857

Review 3.  CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease.

Authors:  Marius Strioga; Vita Pasukoniene; Dainius Characiejus
Journal:  Immunology       Date:  2011-06-29       Impact factor: 7.397

4.  Induction of death receptor CD95 and co-stimulatory molecules CD80 and CD86 by meningococcal capsular polysaccharide-loaded vaccine nanoparticles.

Authors:  Ruhi V Ubale; Rikhav P Gala; Susu M Zughaier; Martin J D'Souza
Journal:  AAPS J       Date:  2014-07-01       Impact factor: 4.009

5.  Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics.

Authors:  Yang Du; Qiannan Fang; Song-Guo Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  A novel T cell-based vaccine capable of stimulating long-term functional CTL memory against B16 melanoma via CD40L signaling.

Authors:  Yufeng Xie; Lu Wang; Andrew Freywald; Mabood Qureshi; Yue Chen; Jim Xiang
Journal:  Cell Mol Immunol       Date:  2012-10-08       Impact factor: 11.530

7.  CD28 days later: Resurrecting costimulation for CD8(+) memory T cells.

Authors:  Verena van der Heide; Dirk Homann
Journal:  Eur J Immunol       Date:  2016-07       Impact factor: 5.532

8.  Expression of toll-like receptors and co-stimulatory molecules in lymphoid tissue during experimental infection of beef calves with bovine viral diarrhea virus of low and high virulence.

Authors:  Roberto A Palomares; Jacqueline Parrish; Amelia R Woolums; Kenny V Brock; David J Hurley
Journal:  Vet Res Commun       Date:  2014-08-23       Impact factor: 2.459

9.  Toxoplasma gondii: immune response and protective efficacy induced by ROP16/GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2.

Authors:  Qi Liu; Fuwu Wang; Guan Wang; Qunli Zhao; Juan Min; Shuai Wang; Hua Cong; Ying Li; Shenyi He; Huaiyu Zhou
Journal:  Hum Vaccin Immunother       Date:  2013-10-07       Impact factor: 3.452

Review 10.  Molecular mechanisms of T cell co-stimulation and co-inhibition.

Authors:  Lieping Chen; Dallas B Flies
Journal:  Nat Rev Immunol       Date:  2013-03-08       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.